Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Podcast: Autonomous labs redefine the role of biopharma researchers

Ginkgo Bioworks CEO Jason Kelly discusses the company’s work on autonomous labs and their impact on biopharma R&D.

Latest news

Novo’s CEO champions “record-breaking start” for Wegovy pill in US market

Novo Nordisk’s Wegovy pill is already providing financial fuel in the company’s bid to catch Eli Lilly.

GSK spends $1bn on rights to SiranBio’s metabolic oligonucleotide

This deal strengthens GSK’s focus on addressing the complications of obesity, while restocking the company’s pipeline amid key patent expiries.

Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn

The acquisition involves Angelini Pharma purchasing all outstanding Catalyst shares for $31.50 per share in cash.

Construction begins on Novartis’ RLT centre in Texas, US

The site is expected to be operational in 2028, adding new roles in advanced manufacturing and bioengineering.

Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing

When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.